HIMS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
HIMS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Hims & Hers Health's Cost of Goods Sold for the three months ended in Sep. 2024 was $84 Mil. Hims & Hers Health's Average Total Inventories for the quarter that ended in Sep. 2024 was $45 Mil. Hims & Hers Health's Inventory Turnover for the quarter that ended in Sep. 2024 was 1.87.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Hims & Hers Health's Days Inventory for the three months ended in Sep. 2024 was 48.91.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Hims & Hers Health's Inventory-to-Revenue for the quarter that ended in Sep. 2024 was 0.11.
The historical data trend for Hims & Hers Health's Inventory Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hims & Hers Health Annual Data | |||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||
Inventory Turnover | 9.00 | 10.13 | 7.88 | 6.73 | 7.13 |
Hims & Hers Health Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Inventory Turnover | Get a 7-Day Free Trial | 1.81 | 1.91 | 1.88 | 1.68 | 1.87 |
Hims & Hers Health's Inventory Turnover for the fiscal year that ended in Dec. 2023 is calculated as
Inventory Turnover (A: Dec. 2023 ) | |||||||
= | Cost of Goods Sold | / | Average Total Inventories | ||||
= | Cost of Goods Sold (A: Dec. 2023 ) | / ( | (Total Inventories (A: Dec. 2022 ) | + | Total Inventories (A: Dec. 2023 )) | / | count ) |
= | 157.051 | / ( | (21.562 | + | 22.464) | / | 2 ) |
= | 157.051 | / | 22.013 | ||||
= | 7.13 |
Hims & Hers Health's Inventory Turnover for the quarter that ended in Sep. 2024 is calculated as
Inventory Turnover (Q: Sep. 2024 ) | |||||||
= | Cost of Goods Sold | / | Average Total Inventories | ||||
= | Cost of Goods Sold (Q: Sep. 2024 ) | / ( | (Total Inventories (Q: Jun. 2024 ) | + | Total Inventories (Q: Sep. 2024 )) | / | count ) |
= | 83.67 | / ( | (40.588 | + | 49.11) | / | 2 ) |
= | 83.67 | / | 44.849 | ||||
= | 1.87 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hims & Hers Health (NYSE:HIMS) Inventory Turnover Explanation
Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Hims & Hers Health's Days Inventory for the three months ended in Sep. 2024 is calculated as:
Days Inventory | = | Average Total Inventories (Q: Sep. 2024 ) | / | Cost of Goods Sold (Q: Sep. 2024 ) | * | Days in Period |
= | 44.849 | / | 83.67 | * | 365 / 4 | |
= | 48.91 |
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Hims & Hers Health's Inventory to Revenue for the quarter that ended in Sep. 2024 is calculated as
Inventory-to-Revenue | = | Average Total Inventories (Q: Sep. 2024 ) | / | Revenue (Q: Sep. 2024 ) |
= | 44.849 | / | 401.556 | |
= | 0.11 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.
Thank you for viewing the detailed overview of Hims & Hers Health's Inventory Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.
Michael Chi | officer: Chief Marketing Officer | 2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123 |
Andrew Dudum | director, 10 percent owner, officer: Chief Executive Officer | 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123 |
Soleil Boughton | officer: See Remarks | 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123 |
Oluyemi Okupe | officer: Chief Financial Officer | 2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123 |
Irene Becklund | officer: Interim PFO/PAO | 2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123 |
Melissa Baird | officer: Chief Operating Officer | 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123 |
David B Wells | director | C/O NETFLIX, INC., 100 WINCHESTER CIRCLE, LOS GATOS CA 95130 |
Patrick Harrison Carroll | officer: Chief Medicall Officer | 2269 CHESTNUT STREET, # 523, SAN FRANCISCO CA 94123 |
Christiane Pendarvis | director | 2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123 |
Lynne Chou O'keefe | director | 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123 |
Alex Bard | director | 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123 |
Jules A. Maltz | director | 3000 SAND HILL ROAD, BUILDING 2, SUITE 250, MENLO PARK CA 94025 |
Ivp Executive Fund Xvi, Llc | 10 percent owner | 3000 SAND HILL ROAD, BUILDING 2, SUITE 2, MENLO PARK CA 94025 |
Somesh Dash | 10 percent owner | 3000 SAND HILL ROAD, BUILDING 2, SUITE 250, MENLO PARK CA 94025 |
Jack Abraham | 10 percent owner | 1 LETTERMAN DRIVE, SUITE C3500, SAN FRANCISCO CA 94129 |
From GuruFocus
By Faizan Farooque • 11-15-2024
By GuruFocus News • 11-07-2024
By GuruFocus News • 11-19-2024
By GuruFocus News • 11-27-2024
By GuruFocus News • 11-05-2024
By GuruFocus News • 11-05-2024
By GuruFocus News • 11-25-2024
By GuruFocus News • 11-25-2024
By GuruFocus News • 11-13-2024
By GuruFocus News • 11-15-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.